Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
41431
CAS Number:
126613-06-7
R -(-)-Bis(trifluorometanosulfonato) de 1,1'-binaftil-2,2'-diilo
Purity:
≥ 96 % (HPLC)
Synonym(s):
( R -(-)-Bis(trifluorometanosulfonato) de 1,1'-bi-2-naftol
Hazmat
Documents
$84.83 /1G
Tamaño
Request Bulk Quote
Información del producto
Número CAS
126613-06-7
Fórmula molecular
C22H12F6O6S2
Peso molecular
0
Número MDL
MFCD00274615
Punto de fusión
82 - 87 °C
Rotación óptica
[α] 20 D = -154 a -135 ° (C = 1 en THF)
Condiciones
Tienda en RT
Información general
Número CAS
126613-06-7
Fórmula molecular
C22H12F6O6S2
Peso molecular
0
Número MDL
MFCD00274615
Punto de fusión
82 - 87 °C
Rotación óptica
[α] 20 D = -154 a -135 ° (C = 1 en THF)
Condiciones
Tienda en RT
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

(R)-(-)-1,1'-Binaphthyl-2,2'-diyl bis(trifluoromethanesulfonate) is widely utilized in research focused on:

  • Asymmetric Synthesis: This compound serves as a chiral auxiliary in asymmetric synthesis, enabling chemists to create specific enantiomers of molecules, which is crucial in pharmaceuticals where the efficacy of a drug can depend on its chirality.
  • Catalysis: It is used in catalytic reactions, particularly in the production of fine chemicals. Its unique structure allows for enhanced reaction rates and selectivity, making it valuable in industrial applications.
  • Material Science: This chemical is applied in developing advanced materials, such as polymers and coatings, that require specific optical or electronic properties, benefiting industries like electronics and coatings.
  • Research in Organocatalysis: It plays a significant role in organocatalysis, where it helps facilitate reactions without the need for metal catalysts, offering a greener alternative in organic synthesis.
  • Pharmaceutical Development: The compound is explored for its potential in drug formulation, particularly in enhancing the solubility and bioavailability of active pharmaceutical ingredients, addressing common challenges in drug delivery.

Citas